G20-G26

Extrapyramidal and movement disorders

The ICD-10 block G20-G26 encompasses a diverse group of neurological conditions characterized by involuntary movements, impaired voluntary movements, or abnormalities in posture and tone, all stemming from dysfunction within the extrapyramidal system. This complex neural network, primarily involving the basal ganglia, substantia nigra, and their connections, plays a crucial role in modulating motor control, maintaining posture, and initiating and coordinating voluntary movements. Disorders within this category are broadly classified into hypokinetic (reduced movement) and hyperkinetic (excessive movement) types. Hypokinetic disorders are exemplified by Parkinson's disease (G20), which is a progressive neurodegenerative disorder primarily affecting dopamine-producing neurons in the substantia nigra, leading to classic motor symptoms such as bradykinesia (slowness of movement), rigidity, tremor at rest, and postural instability. This category also includes secondary parkinsonism (G21), which can result from drugs, other neurological conditions, or environmental toxins, mimicking idiopathic Parkinson's disease. Hyperkinetic disorders, on the other hand, involve an excess of involuntary movements. This includes conditions like essential tremor (G25.0), a common neurological disorder causing rhythmic, involuntary shaking; various forms of dystonia (G24), characterized by sustained or intermittent muscle contractions causing twisting and repetitive movements or abnormal fixed postures; chorea (G25.5), which involves brief, irregular, unpredictable muscle jerks; tics (G25.6), sudden, repetitive, nonrhythmic motor movements or vocalizations; and other specified or unspecified extrapyramidal and movement disorders (G25, G26). This ICD-10 block serves to classify these conditions based on their primary clinical presentation and presumed underlying pathophysiology. It is critical for clinicians to accurately diagnose and differentiate these disorders, as their etiologies can range from idiopathic neurodegeneration, genetic mutations, autoimmune processes, metabolic derangements, infections, structural brain lesions, to medication side effects. While this category provides a framework for classification, precise diagnosis of specific conditions within this range often requires detailed neurological examination, imaging, and sometimes genetic or laboratory testing to guide appropriate management strategies. This non-billable category code provides the umbrella under which more specific, billable diagnoses are found.

Clinical Symptoms

  • Tremors (resting or action)
  • Bradykinesia (slowness of movement)
  • Rigidity
  • Dystonia (sustained muscle contractions)
  • Chorea (involuntary, irregular jerking movements)
  • Athetosis (slow, writhing movements)
  • Ballism (large, flinging movements)
  • Tics (sudden, repetitive motor or vocal movements)
  • Myoclonus (sudden, brief muscle jerks)
  • Gait disturbances
  • Postural instability
  • Impaired balance

Common Causes

  • Neurodegeneration (e.g., Parkinson's disease)
  • Genetic factors (e.g., Huntington's disease, inherited dystonias)
  • Medication side effects (e.g., antipsychotics causing tardive dyskinesia)
  • Brain injury or stroke affecting basal ganglia
  • Infections (e.g., post-encephalitic parkinsonism)
  • Metabolic disorders (e.g., Wilson's disease)
  • Autoimmune conditions
  • Exposure to toxins (e.g., manganese, MPTP)
  • Idiopathic (cause unknown)

Documentation & Coding Tips

Always specify the exact type and etiology of the extrapyramidal or movement disorder. Avoid general terms and use the most specific ICD-10 code available.

Example: POOR DOCUMENTATION: "Patient seen for tremors and difficulty walking, likely Parkinson's. Continue current meds." EXCELLENT DOCUMENTATION: "Patient, 72 y.o. male, presents for follow-up of diagnosed Parkinson's disease (G20.A1 - Parkinson's disease without dyskinesia, without mention of fluctuations). Patient exhibits classic triad of resting tremor (right hand predominant), bradykinesia, and postural instability leading to two documented falls in the last 3 months (R29.6). Modified Hoehn and Yahr Stage 3. Patient also reports mild dysphagia (R13.10) requiring thickened liquids, and chronic constipation (K59.00) well controlled with PEG. These comorbidities contribute significantly to the overall burden of illness. Continue Carbidopa/Levodopa BID. Discussed PT for gait training and OT for ADL support. Plan to assess for medication-induced dyskinesia at next visit to refine G20 sub-classification."

Billing Focus: Specifying G20.A1 (Parkinson's) versus a less specific code like G20 or a symptom code (R25.x) justifies the medical necessity of Parkinson's-specific treatments and follow-up. Documenting laterality (right hand predominant) for tremor adds clinical detail, supporting specific interventions if needed. Documenting related complications like falls (R29.6) and dysphagia (R13.10) provides full picture for billing the encounter's complexity.

Clearly document the presence or absence of complications, associated symptoms, and functional limitations related to the movement disorder.

Example: POOR DOCUMENTATION: "Patient with dystonia, feels stiff." EXCELLENT DOCUMENTATION: "Patient, 48 y.o. female, presents with idiopathic focal dystonia (G24.3 - Spasmodic torticollis) affecting cervical musculature, resulting in chronic, painful, involuntary head rotation to the right (R25.8). This has led to significant functional impairment in driving and computer work, requiring occupational therapy intervention (Z91.810 - History of falling). Patient also reports chronic neck pain (M54.2) and tension headaches (G44.209) associated with muscle spasm. No evidence of drug-induced etiology. Consider botulinum toxin injection to affected sternocleidomastoid and trapezius muscles. Discussed impact on mental health and screening for anxiety (F41.9)."

Billing Focus: Documenting specific complications (e.g., M54.2 for neck pain, G44.209 for headaches) and functional impairments (impact on driving/work, requiring OT) supports the medical necessity for diagnostic tests, specialist consultations, and therapeutic interventions (e.g., botulinum toxin injections, physical therapy) and higher E/M coding due to increased complexity.

For secondary movement disorders (e.g., G21, G25.1), always specify the underlying cause or contributing factor.

Example: POOR DOCUMENTATION: "Patient has parkinsonism, likely due to medication." EXCELLENT DOCUMENTATION: "Patient, 65 y.o. male, presents with new onset bradykinesia and rigidity following initiation of olanzapine 3 months ago for bipolar disorder (F31.9). Diagnosis of drug-induced parkinsonism (G21.19 - Other drug induced secondary parkinsonism) confirmed after careful medication reconciliation and neurological exam. Symptoms significantly impact ambulation and fine motor tasks. Olanzapine dose reduced after discussion with psychiatry, and initiation of trihexyphenidyl considered if symptoms persist. Patient denies history of idiopathic Parkinson's disease or other neurological disorders. This secondary parkinsonism represents a new and acute exacerbation of his overall medical complexity, directly linked to iatrogenic factors and requiring careful management to prevent further decline."

Billing Focus: Documenting the specific drug (olanzapine) and linking it directly to the parkinsonism (G21.19) clearly justifies the diagnostic evaluation, medication adjustments, and ongoing management. This specificity avoids unbundling issues and supports medical necessity for interventions aimed at mitigating the drug's side effect. It also supports higher E/M level due to managing a complex drug-related adverse event.

Relevant CPT Codes

Related Diagnoses

Hierarchy